Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „warfarin“
Suchtreffer
Begriffe & Kennungen
Ablymico · 4.5 · Warfarin and other coumarin derivatives
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · CYP2C9 substrates (e.g.R-warfarin) Tadalafil (10 mg and 20 mg) had no clinically significant effect on exposur
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.5 · CYP2C9 substrates (e.g.R-warfarin) Tadalafil (10 mg and 20 mg) had no clinically significant effect on exposur
Eintrag öffnenAdempas · 4.5 · Warfarin/phenprocoumon Concomitant treatment of riociguat and warfarin did not alter prothrombin time induced
Eintrag öffnenAdempas · 4.5 · Warfarin/phenprocoumon Concomitant treatment of riociguat and warfarin did not alter prothrombin time induced
Eintrag öffnenAdenuric · 4.5 · Colchicine/indometacin/hydrochlorothiazide/warfarin
Eintrag öffnenAdenuric · 4.5 · Colchicine/indometacin/hydrochlorothiazide/warfarin Febuxostat can be co-administered with colchicine or indom
Eintrag öffnenAdenuric · 4.5 · No dose adjustment is necessary for warfarin when administered with febuxostat. Administration of febuxostat (
Eintrag öffnenAdenuric · 4.5 · No dose adjustment is necessary for warfarin when administered with febuxostat. Administration of febuxostat (
Eintrag öffnenAdtralza · 4.5 · The effects of tralokinumab on the pharmacokinetics (PK) of CYP substrates, caffeine (CYP1A2), warfarin (CYP2C
Eintrag öffnenAlli (previously Orlistat GSK) · 4.5 · When warfarin or other oral anticoagulants are given in combination with orlistat, international normalised ra
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · 6 Warfarin
Eintrag öffnenAmbrisentan Viatris (previously Ambrisentan Mylan) · 4.5 · Ambrisentan had no effects on the steady-state pharmacokinetics and anti-coagulant activity of warfarin in a h
Eintrag öffnenAptivus · 4.5 · 18 Antithrombotics Warfarin 10 mg QD First-dose tipranavir/r: Aptivus, co-administered with S-warfarin Cmax ↔
Eintrag öffnenArava · 4.5 · Effect on warfarin (CYP2C9 substrate) Repeated doses of A771726 had no effect on the pharmacokinetics of S-war
Eintrag öffnenArava · 4.5 · Effect on warfarin (CYP2C9 substrate) Repeated doses of A771726 had no effect on the pharmacokinetics of S-war
Eintrag öffnenArava · 4.5 · Effect on warfarin (CYP2C9 substrate) Repeated doses of A771726 had no effect on the pharmacokinetics of S-war
Eintrag öffnenArava · 4.5 · There have been case reports of increased prothrombin time, when leflunomide and warfarin were co-administered
Eintrag öffnenArava · 4.5 · There have been case reports of increased prothrombin time, when leflunomide and warfarin were co-administered
Eintrag öffnenArava · 4.5 · There have been case reports of increased prothrombin time, when leflunomide and warfarin were co-administered
Eintrag öffnen